<unk>  (Liposomal cisplatin) is a nanoparticle of 110 nm average diameter composed of lipids and cisplatin. This new drug has successfully finished Phase I, Phase II, and Phase III human clinical trials. It has shown superiority to cisplatin in combination with paclitaxel as a chemotherapy regimen in non-small cell lung cancer (NSCLC) adenocarcinomas.
Lipoplatin
Ifosfamide
Carboplatin
Doxorubicin
Paclitaxel
Lomustine
Bendamustine
Etoposide